pembrolizumab
merck
['keytruda', 'merck']
 is going strong in #oncology and #immunotherapy with its blockbuster product keytruda, that grew % cagr in the last five years. excited to see #whatsnext #esmo22 follow us 
A healthcare-focused strategy consulting firm, providing bench-to-bedside decision support to pharmaceutical, biotech, and medical device companies